Document Type : Original Article


Faculty of Pharmacy, Dit University, Dehradun, 248001, India


The aim of research work was to formulate bio-flexy films using a novel biopolymer isolated from Rosa polyanthapetals containing tiagabine as a model drug. The soft palate drug delivery helps bypass first-pass metabolism in the liver and pre-systemic elimination in the gastrointestinal tract gets avoided. Tiagabine, anticonvulsant drug possesses t1/2:7-9 hours (low); protein binding: 96%; water solubility: 22mg/L enhances acts as selective GABA reuptake inhibitor. Side effects include abdominal pain, pharyngitis, suicidal thoughts and sudden unexpected death. Rosa polyantha biopolymer used as bio-excipient due to its biodegradability, biocompatibility, non-toxicity, non-reactiveness on soft palatal surface. Physicochemical characterization of biopolymer displayed inbuilt filmability, mucoadhesivity properties. Bio-flexy films were prepared by solvent casting technique. Formulations containing different ratios of nanosized Tiagabine: Rosa polyantha biopolymer (1:0.5, 1:1; 1:3, 1:5, 1:6, 1:10) (FRT1-FRT6) were prepared and compared with nanosized Tiagabine loaded Sodium CMC standard flexy films (FET1-FET6). The percentage yield of Rosa polyantha biopolymer was found to be 2.24±0.01%. Evaluation parameters for formulations revealed Thickness of nanosized Tiagabine loaded bio-flexy films containing Rosa polyantha biopolymer (FRT1-FRT6): 0.027 mm±0.005 to 0.039±0.004 mm, Folding Endurance: 83-130, Surface pH: 7.00±0.04 to 7.00±0.01, Weight Uniformity: 0.008±0.05 to 0.044±0.03, Drug Content Uniformity: 85.6%±0.48 to 94.8%±0.37, Swelling Percentage: 66%±0.2 to 75%±0.1, Percentage Moisture Uptake (PTU): 2.5%±0.14 to 3.8%±0.10. Mucoadhesivity: 90-1440 mins, Mucoretentivity: 110-240 mins. Drug release pattern for formulations FRT1-FRT6 containing Rosa polyantha biopolymer based on the T50% and T80% was found to be FRT5 (1:6) > FRT4 (1:5) > FRT6 (1:10) > FRT1 (1:0.5)> FRT3 (1:3) > FRT2 (1:1). Based on all above mentioned evaluation parameters, FRT5 (containing Tiagabine: Rosa polyantha biopolymer (1:6)) bio-flexy film having R2= 0.9295, Higuchi Matrix as best fit model, follows Fickian Diffusion (Higuchi Matrix) release mechanism, T50%: 7hrs., T80%: 30 hrs. using BITS Software 1.12 was found to be Best formulation.

Graphical Abstract

Bio-flexy film formulation for delivery of tiagabine via oro trans-soft palatal route and its in-vitro stability study approach


Main Subjects

[1]. Danzer S. Neuron Journal, 2012, 75:739
[2]. Pulman J., Marson A.G., Hutton J.L. Europe PMC., 2014, 2:1
[3]. Shakya P., Madhav N.V.S., Shakya A.K. J. Control Release., 2011, 151:2
[4]. Kalviainen R. Epilepsia Journal, 2001, 42:45
[5]. Sharma Y., Hegde R.V., Venugopal C.K. International Journal of Research in Ayurveda and Pharmacy, 2011, 2:375
[6]. Karki S., Kim H., JeongNa S., Shin D., Jo K., Lee J. Asian Journal of Pharmaceutical Sciences.2011, 11:559
[7]. Satheesh Madhav N.V., Semwal R. Expert Opinion on Drug Delivery 2012, 9:629
[8]. Nilani P., Duraisamy B., Dhamodaran P., Elango K. Journal of Pharmaceutical Sciences and Research, 2010, 2:178
[9]. Patil S., Asema S.U.K., Mirza S., International Journal of Chemical Sciences. 2008, 6:413
[10]. Satheesh Madhav N.V., Singh K. Journal of Applied Pharmaceutical Research, 2017, 5:21
[11]. Patil S, Asema S.U.K. International Journal of Chemical  Sciences, 2008,6:413
[12]. Madhav N.V.S., Tangri P. International  Journal of Therapeutic Applications, 2012, 4:10
[13]. Satheesh Madhav N V, Varshney S. Journal of Molecular Medicine and Clinical Applications. Sci. Forschen, 2017, 1.1:1